Equifax (EFX) Competitors $252.52 +2.85 (+1.14%) Closing price 09/8/2025 03:58 PM EasternExtended Trading$252.97 +0.46 (+0.18%) As of 09/8/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EFX vs. CCRN, CRAI, APTV, FI, G, IQV, OMC, RHI, TRU, and WMShould you be buying Equifax stock or one of its competitors? The main competitors of Equifax include Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Aptiv (APTV), Fiserv (FI), Genpact (G), IQVIA (IQV), Omnicom Group (OMC), Robert Half (RHI), TransUnion (TRU), and Waste Management (WM). Equifax vs. Its Competitors Cross Country Healthcare Charles River Associates Aptiv Fiserv Genpact IQVIA Omnicom Group Robert Half TransUnion Waste Management Equifax (NYSE:EFX) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings. Do institutionals and insiders have more ownership in EFX or CCRN? 96.2% of Equifax shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 1.4% of Equifax shares are held by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media favor EFX or CCRN? In the previous week, Equifax had 14 more articles in the media than Cross Country Healthcare. MarketBeat recorded 18 mentions for Equifax and 4 mentions for Cross Country Healthcare. Equifax's average media sentiment score of 1.37 beat Cross Country Healthcare's score of 1.27 indicating that Equifax is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Equifax 13 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, EFX or CCRN? Equifax has a beta of 1.68, suggesting that its share price is 68% more volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Do analysts prefer EFX or CCRN? Equifax currently has a consensus target price of $283.53, indicating a potential upside of 12.28%. Cross Country Healthcare has a consensus target price of $17.93, indicating a potential upside of 27.62%. Given Cross Country Healthcare's higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than Equifax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Equifax 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.74Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is EFX or CCRN more profitable? Equifax has a net margin of 10.95% compared to Cross Country Healthcare's net margin of -0.70%. Equifax's return on equity of 18.89% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Equifax10.95% 18.89% 7.84% Cross Country Healthcare -0.70%1.72%1.24% Which has preferable valuation and earnings, EFX or CCRN? Equifax has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEquifax$5.68B5.50$604.10M$5.1149.42Cross Country Healthcare$1.34B0.34-$14.56M-$0.26-54.04 SummaryEquifax beats Cross Country Healthcare on 15 of the 17 factors compared between the two stocks. Get Equifax News Delivered to You Automatically Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFX vs. The Competition Export to ExcelMetricEquifaxConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$30.91B$6.69B$26.47B$21.38BDividend Yield0.80%1.71%2.74%3.49%P/E Ratio49.4223.3727.1629.64Price / Sales5.502.68695.9948.98Price / Cash19.4516.5925.6018.12Price / Book6.505.397.044.59Net Income$604.10M$272.15M$199.14M$999.86M7 Day Performance7.89%0.31%8.52%1.13%1 Month Performance5.26%0.92%16.99%5.61%1 Year Performance-15.09%-7.65%51.01%16.98% Equifax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFXEquifax4.7484 of 5 stars$252.52+1.1%$283.53+12.3%-13.5%$30.91B$5.68B49.4214,700Positive NewsCCRNCross Country Healthcare3.5391 of 5 stars$13.38+0.1%$17.93+34.0%+3.4%$438.33M$1.34B-51.468,205Positive NewsCRAICharles River Associates3.7289 of 5 stars$193.76-1.1%$228.00+17.7%+21.8%$1.28B$712.91M23.46940Positive NewsAPTVAptiv4.3141 of 5 stars$79.68-0.8%$81.81+2.7%+20.1%$17.35B$19.71B18.23141,000Positive NewsAnalyst DowngradeFIFiserv4.9644 of 5 stars$138.09+0.3%$207.36+50.2%-20.6%$75.07B$383.42M23.0538,000Trending NewsGGenpact4.1235 of 5 stars$45.33+0.8%$52.29+15.3%+15.5%$7.90B$4.77B15.06140,000IQVIQVIA4.9506 of 5 stars$190.71+1.0%$228.62+19.9%-22.8%$32.42B$15.70B27.6088,000Positive NewsOMCOmnicom Group4.771 of 5 stars$78.34+0.8%$94.43+20.5%-20.0%$15.18B$15.91B11.2474,900Positive NewsRHIRobert Half4.8938 of 5 stars$37.37+2.3%$45.83+22.7%-40.8%$3.80B$5.80B21.3514,700Positive NewsTRUTransUnion4.8524 of 5 stars$88.41-0.3%$112.46+27.2%-0.5%$17.22B$4.18B44.2113,400Insider TradeGap UpWMWaste Management4.867 of 5 stars$226.69+0.9%$254.35+12.2%+7.0%$91.32B$22.06B33.6361,700 Related Companies and Tools Related Companies Cross Country Healthcare Alternatives Charles River Associates Alternatives Aptiv Alternatives Fiserv Alternatives Genpact Alternatives IQVIA Alternatives Omnicom Group Alternatives Robert Half Alternatives TransUnion Alternatives Waste Management Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EFX) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equifax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equifax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EFX Stock Alerts